Meprobamate

This classification denotes a sedative, hypnotic, and anticonvulsant agent with the molecular formula C9H18N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I7LNY769Q, chemically known as 1,3-propanediol, 2-methyl-2-propyl-, carbamate isopropylcarbamate (ester) but generally known as meprobamate, which bears US NIH Compound Identifier 2576. European Medicines Agency schedules Meprobamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08757MIG. The term MEPROBAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules meprobamate in its Anatomical Therapeutic Chemical (ATC) Classification. MEPROBAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meprobamate under HS 29241100 and SITC 51471. As of Q4 2014, MEPROBAMATE remains the US FDA Preferred Term for this commodity. Meprobamate bears US NLM identifiers UMLS ID C0025386 and NCI Concept Code C47603. SMILES: O(CC(CCC)(COC(=O)N)C)C(=O)NC(C)C.